ECN News

Within the framework of a collaboration between St. Jude Children’s Research Hospital, US and Hospital 57357: Graduation of a contagious diseases and infection control international program cohort

Hospital 57357 celebrated the graduation of a cohort of trainees enrolled in the international program of contagious diseases and infection control that was organized by St. Jude’s Global School, in cooperation with Hospital 57357. 57357 participation in this program is considered as worldwide recognition of its stature and potential, and that it became an accredited […]

Read more

Children’s Cancer Hospital 57357 received the visit of Prof. Dr. Hisham El Seify, member of the Board of Directors of Hospital 57357 Foundation and President of Egypt cancer network USA.

During the visit, Dr. Hisham El Seify visited various departments inside the hospital and the new Cyberknife treatment technology building, in addition to visiting the new creation center and new playing area funded with the support of the Egypt cancer network USA. Dr. Hisham El Seify said: In my frequent visits to Hospital 57357, I […]

Read more

Ayan’s mother: my son is receiving utmost care in 57357, and I started collecting donations from friends to support the other children

Ayan from Suez, is 4 years old. He started his treatment journey in Hospital 57357 a week ago. “We discovered Ayan’s sickness by chance, when he fell on his head while playing with his relatives”, shared Ayan’s mother. We hurried to the Hospital where he had x-rays on his arm, leg and brain. It was […]

Read more

During their recent visit to 57357: World cancer experts praise 57357’s acquisition and launch of the Cyberknife technology

Hospital 57357 welcomed the visits of Prof. Dr. Nobert Graf, professor of pediatric oncology in Saarland University, Germany, head of SIOP’s renal tumors work group & member of the Children’s Oncology Group, COG, in North America, Dr. Lee Cooper, pathology professor at Northwestern University, USA, and Dr. Zeinab Afifi, professor of  pediatric oncology at Utah […]

Read more

Abdallah’s mother:” CCHE57357 is giving my son a fresh start’

Today we want  to introduce you to Abdallah, another 57357 patient hero. Abdallah is a 6 year old active outgoing boy who loves to draw and to play soccer for his school’s football team. At the beginning of the academic year of 2021, the active player felt suddenly so sick that he couldn’t finish the […]

Read more

CCHE57357 posts a new research addressing patterns and outcomes of a rare syndrome when combined with neuroblastoma patients

A research study that included 15 Egyptian pediatric oncology patients addresses patterns and outcomes of Ataxia syndrome when accompanied by neuroblastoma published by a pediatric oncology consultant at CCHE57375.  The Opsoclonus myoclonus ataxia syndrome (OMAS) is a rare primarily immune-mediated disease in the nervous system of children that is characterized by unusual movements of the […]

Read more

Patient Alaa praises 57357, saying: “CCHE57357 goes an extra mile to enable patients to defeat cancer ‘

In 2020, Alaa was 17 years old when she started suffering from a severe headache and  continuous fever   for a whole week. Then, she suddenly lost sight in one of her eyes. The following day her condition turned out to be even worse as she suddenly lost her hearing capacity of one ear. The regular […]

Read more

Recent study by CCHE57357’s proteomics and Metabolomics team reveals: Two protein complexes were found to hinder a certain type of chemotherapy used in treating thyroid cancer

In collaboration with Tulane University, U.S., CCHE57357’s proteomics and metabolomics unit recently posted a research paper that demonstrates the relation between the presence of two protein complexes and the resistivity against chemotherapy used in the treatment of thyroid cancer patients. The study detected that some patients who suffered from thyroid cancer, were reported to have […]

Read more

A recently published research by CCHE 57357’S Genomics team showcases a non-invasive diagnostic biomarker for Acute Myeloid leukemia patients

CCHE genomics team recently published a research paper in the Cancer biomarker journal, that confirms the positive relevance /correlation between a specific gene expression in a patient’s blood and early tumor detection in AML patients Early detection contributes to better clinical outcomes for AML patients who make up to 20%of pediatric leukemia and account for […]

Read more

CCHE57357’s researchers conduct a systematic study to evaluate leukemia relapse treatment drugs in terms of effectiveness and cost

A systematic review Researchers at Children’s cancer Hospital 57357 conducted a systematic study to evaluate drugs used in treating acute leukemia relapse by linking their effectiveness to their economic cost. The study was published in Expert review of hematology magazine with an impact factor of 2.8 that was  conducted in collaboration with the University of […]

Read more

Patient Mohamed “CCHE57357’s Daycare unit staff motivated me to excel in sports after conquering cancer”

Mohamed, 12 years old, is an active soccer player for a well know club, and never missed a training session with his team. During one of the football matches, he got injured. His coach and parents thought that getting some rest and topical medications will work for a common sports injury. Unfortunately, the pain persisted. […]

Read more

Patient Norhan “The celebration of my last day of chemotherapy at the CCHE57357 was the kick-off of a new life chapter as a cancer survivor”

“I learned a new lesson about what patience and persistence can bring forth during my treatment journey at CCHE57357”, says Norhan Mohamed, our new survivor In 2016 Norhan’s regular pediatrician couldn’t give an accurate diagnosis of her illness as she suffered an enlarged lymph node in her left arm and suggested her referral to CCHE57357. […]

Read more

CCHE57357 celebrates World food safety day under the slogan “safe food for a better health”

Last week on July 21, 2022, CCHE57357 celebrated world’s international food safety day with a 2 day event that captured the attention of local and regional media channels. Under the slogan “Safe food for better health” the event was held on CCHE57357 premises and aimed at raising public awareness about food safety in the Egyptian […]

Read more

Al Saify, ECN US president, during his recent visit to the Children’s Cancer Hospital Egypt 57357

“CCHE57357’S acquisition of the Cyber knife is a milestone for Egypt, Africa and the Middle East in the medical field” “Congratulations 57357… every time I come, I find progress, even in times of global crisis” Early this month, Dr. Hisham Al Saify, plastic surgeon and president of Egypt cancer network U.S   was on a visit […]

Read more

Mostafa’s Mother “Strenuous medical efforts of CCHE57357’s care team givers have contributed to my son’s recovery from cancer”

Mostafa was in a deep coma until a miracle happened and he regained consciousness, a new patient success story at the Children’s Cancer Hospital Egypt 57357.  The story of our new survivor started when symptoms of illness came back after he had finished a prescribed course of antibiotics. His parents thought their visit to his regular pediatrician would help and be enough to get the right treatment. Unfortunately, lab […]

Read more

Research findings correlate poor outcomes of hematological malignancy patients with covid19 which may improve patients’ clinical management

A research collaborator based at the Children’s Cancer Hospital 57357 participated in a research project and spotted the reasons behind poor outcomes of hematology patients who tested positive for covid19. Hematology patients were found to develop lethal complications when tested positive for Covid19. “The research study highlights factors leading to mortality in patients with hematological […]

Read more

Findings of a new research paper by CCHE57357’S proteomics team reveal a potential antivirus for covid 19 in humans and bronchitis in birds

A novel research paper conducted by the proteomics and metabolomics unit discloses the capability of the discharges of mesenchymal stem cells derived from the umbilical cord to fight corona virus in human and infectious bronchitis in birds. The paper, posted in cells magazine with impact factor 6.6, verified that the discharges contained immunoprotiens and antiviruses. […]

Read more

Mohamed’s mom: “CCHE57357 granted my son to resume living a cancer- free life”

Mohamed developed painful lesions and rash on his face and scalp, strange symptoms that needed to be addressed and required an explanation. His pediatrician suggested his referral to CCHE57357 because of the hospital’s valuable experience within the field of pediatric oncology in Egypt.   Mohamed’s parents traveled from their hometown to Cairo and brought him to CCHE57357’s screening clinic along with his preliminary tests to get an […]

Read more

A new research paper by 57357’s proteomics unit suggests a natural substance that may combat hepatotoxicity caused by chemo drug Methotrexate

Finally coming to light after a whole year of testing and verifying  carried out on animals, a research paper by CCHE57357’s proteomics& metabolomics team reveals the impact of a natural substance on toxicity of a certain type of chemotherapy. Methotrexate chemotherapy is widely known for its usage in treating many types of cancer and for […]

Read more

CCHE57357’s Genomics research release gives better understanding of a multi- drug resistant bacteria which may enhance patients’ outcomes

A new paper release conducted by CCHE57357’s genomics  research team gives a better genetic understanding of Klebsiella pneumonia  (certain type of bacterial infection) which ultimately helps in reaching enhanced patients’ clinical outcomes.   Hospitalized patients in general and immuno-compromised ones in particular were found to suffer from bacterial infections among which the one causing inflammation […]

Read more

A triumphant victory over Erdheim Chester disease

Mohamed, a playful kid, was only three when he came to CCHE57357’s screening clinic suffering from a skin rash, bulging eye balls and a fever.  His parents never expected such a malicious condition until the results of the preliminary examinations confirmed his serious illness. Mohamed was diagnosed with a rare disease named Erdheim–Chester disease.  Erdheim– […]

Read more

Blessed Eid Wishes from ECN,

The Holy Month is already coming to an end! May the upcoming Eid be a blessed time of   joyful gatherings and celebrations with family and friends! In spite of the political circumstances and economic instability resulting from the war in Ukraine, we still wish you the best on this occasion, and may the Eid bring […]

Read more

Best wishes from ECN for the start of Ramadan!

With Ramadan around the corner, we wish our ECN donors, supporters, and chapter leaders in the US and Canada, a blessed time filled with health, serenity, and the meaningful things of life:  togetherness and supporting one another and the most vulnerable around us. With the war outbreak in Ukraine, the future seems again so uncertain. […]

Read more

CCHE57357 research reveals a new clue that can positively affect the survival rate of some pediatric patients diagnosed with Acute Myeloid Leukemia(AML)

A new research paper suggests the  pretreatment screening for MECOM gene overexpression in newly diagnosed AML patients for better risk stratification and thus treatment adjustment which will improve the survival rates. “Despite advances in the treatment of AML, relapse remains a major problem. While some children can be risk-stratified based on cytogenetic or molecular findings, […]

Read more

CCHE 57357 receives the international JCI accreditation for the third time consecutively

In a scene that was filled with the joy of achievement, CCHE 57357 staff were applauded upon the announcement of the JCI surveyors panel granting the Joint Commission accreditation for the third time in a row. During a visit that lasted for a whole week, Joint Commission International surveyors have audited the hospital’s medical and […]

Read more